Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan

PML caused by John Cunningham (JC) virus is a rare but an increasingly recognized entity. With the advent of newer immunomodulatory therapies with monoclonal antibodies, there is an increasing incidence of PML. Initially concern was restricted to patients treated for multiple sclerosis with natalizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Michael A., Renga, Vijay, Pachner, Andrew R., Cohen, Jeffrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326342/
https://www.ncbi.nlm.nih.gov/pubmed/25705531
http://dx.doi.org/10.1155/2015/892047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326342/
https://www.ncbi.nlm.nih.gov/pubmed/25705531
http://dx.doi.org/10.1155/2015/892047

Ejemplares similares